Progyny Inc. [NASDAQ: PGNY] closed the trading session at $52.97 on 04/16/21. The day’s price range saw the stock hit a low of $52.88, while the highest price level was $55.00. The company report on April 16, 2021 that PTC Set to Join S&P 500; Lattice Semiconductor & Progyny to Join S&P MidCap 400; Domtar to Join S&P SmallCap 600.
S&P Dow Jones Indices will make the following changes to the S&P 500, S&P MidCap 400, and S&P SmallCap 600 effective prior to the open of trading on Tuesday, April 20:.
S&P MidCap 400 constituent PTC Inc. (NASD:PTC) will replace Varian Medical Systems Inc. (NYSE:VAR) in the S&P 500, and Lattice Semiconductor Co. (NASD:LSCC) will replace PTC in the S&P MidCap 400. Siemens Healthineers AG (XETR: SHL) acquired Varian Medical Systems Inc. in a deal that closed, April 15.
The stocks have a year to date performance of 24.96 percent and weekly performance of 11.52 percent. The stock has been moved at 84.24 percent over the last six months. The stock has performed 8.70 percent around the most recent 30 days and changed 17.84 percent over the most recent 3-months.
If compared to the average trading volume of 742.01K shares, PGNY reached to a volume of 4554590 in the most recent trading day, which is why market watchdogs consider the stock to be active.
Here’s what leading stock market gurus have to say about Progyny Inc. [PGNY]:
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for PGNY shares is $53.75 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on PGNY stock is a recommendation set at 1.00. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
BofA Securities have made an estimate for Progyny Inc. shares, keeping their opinion on the stock as Buy, with their previous recommendation back on March 10, 2021. While these analysts kept the previous recommendation, SVB Leerink raised their target price to Outperform. The new note on the price target was released on July 01, 2020, representing the official price target for Progyny Inc. stock. Previously, the target price had yet another raise to $30, while Guggenheim analysts kept a Buy rating on PGNY stock.
The Average True Range (ATR) for Progyny Inc. is set at 2.21, with the Price to Sales ratio for PGNY stock in the period of the last 12 months amounting to 12.72. The Price to Book ratio for the last quarter was 27.59, with the Price to Cash per share for the same quarter was set at 1.32. Price to Free Cash Flow for PGNY in the course of the last twelve months was 124.68 with Quick ratio for the last quarter at 2.40.
PGNY stock trade performance evaluation
Progyny Inc. [PGNY] gain into the green zone at the end of the last week, gaining into a positive trend and gaining by 11.52. With this latest performance, PGNY shares gained by 8.70% in over the last four-week period, additionally plugging by 84.24% over the last 6 months – not to mention a rise of 159.66% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for PGNY stock in for the last two-week period is set at 68.86, with the RSI for the last a single of trading hit 78.44, and the three-weeks RSI is set at 63.54 for Progyny Inc. [PGNY]. The present Moving Average for the last 50 days of trading for this stock 47.17, while it was recorded at 49.78 for the last single week of trading, and 36.10 for the last 200 days.
Progyny Inc. [PGNY]: An insightful look at the core fundamentals
Operating Margin for any stock indicates how profitable investing would be, and Progyny Inc. [PGNY] shares currently have an operating margin of +2.42 and a Gross Margin at +20.32. Progyny Inc.’s Net Margin is presently recorded at +13.47.
Return on Total Capital for PGNY is now 5.77, given the latest momentum, and Return on Invested Capital for the company is 32.09. Return on Equity for this stock inclined to 33.04, with Return on Assets sitting at 22.98. When it comes to the capital structure of this company, Progyny Inc. [PGNY] has a Total Debt to Total Equity ratio set at 4.98. Additionally, PGNY Total Debt to Total Capital is recorded at 4.75, with Total Debt to Total Assets ending up at 3.28. Long-Term Debt to Equity for the company is recorded at 4.98, with the Long-Term Debt to Total Capital now at 4.75.
Reflecting on the efficiency of the workforce at the company, Progyny Inc. [PGNY] managed to generate an average of $221,233 per employee. Receivables Turnover for the company is 5.62 with a Total Asset Turnover recorded at a value of 1.71.Progyny Inc.’s liquidity data is similarly interesting compelling, with a Quick Ratio of 2.40 and a Current Ratio set at 2.40.
Earnings per share (EPS) analysis for Progyny Inc. [PGNY] stock
With the latest financial reports released by the company, Progyny Inc. posted 0.04/share EPS, while the average EPS was predicted by analysts to be reported at 0.02/share. When compared, the two values demonstrate that the company surpassed the estimates by a Surprise Factor of 100.00%. The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for PGNY. When it comes to the mentioned value, analysts are expecting to see the 5-year EPS growth rate for Progyny Inc. go to 60.55%.
Progyny Inc. [PGNY]: Insider Ownership positions
There are presently around $3,727 million, or 87.40% of PGNY stock, in the hands of institutional investors. The top three institutional holders of PGNY stocks are: TPG GROUP HOLDINGS (SBS) ADVISORS, INC. with ownership of 14,725,118, which is approximately -13.331% of the company’s market cap and around 1.60% of the total institutional ownership; KPCB XIII ASSOCIATES, LLC, holding 11,093,696 shares of the stock with an approximate value of $587.63 million in PGNY stocks shares; and MACQUARIE GROUP LTD, currently with $285.31 million in PGNY stock with ownership of nearly 10.879% of the company’s market capitalization.
Positions in Progyny Inc. stocks held by institutional investors increased at the end of May and at the time of the May reporting period, where 132 institutional holders increased their position in Progyny Inc. [NASDAQ:PGNY] by around 23,533,255 shares. Additionally, 43 investors decreased positions by around 4,692,004 shares, while 25 investors held positions by with 42,132,343 shares. The mentioned changes placed institutional holdings at 70,357,602 shares, according to the latest SEC report filing. PGNY stock had 58 new institutional investments in for a total of 14,803,445 shares, while 13 institutional investors sold positions of 1,444,200 shares during the same period.